Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Agnosia × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Pain 2 Colonic Neoplasms 2 Choledochal Cyst 2 Urinary Bladder Neoplasms 1 Terminal Cancer 1 Solid Tumor 1 Skin Neoplasms 1 Sedation 1 Rectal Neoplasms 1 Postoperative Cognitive Complications 1 Polyps 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Pain, Postoperative 1 Pain, Intractable 1 Opioid-Related Disorders 1 Nausea 1 Mouth Neoplasms 1 Healthy 1 Glioma 1 Gastrointestinal Stromal Tumors 1 Fractures, Bone 1 Female Patients Under the Age of 65 Who Will Undergo Breast Cancer Surgery 1 Emergence Delirium 1 Dyspnea 1 Diverticulosis, Colonic 1

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Analgesics, Opioid 7 Ropivacaine 6 Anesthesia, General 6 Acetaminophen 6 Lidocaine 5 Fentanyl 5 Acupuncture Therapy 5 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Morphine 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 Transcutaneous Electric Nerve Stimulation 2 Tea 2 Pregabalin 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04597268 2023-01-10

Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures

National Cancer Institute, Egypt

Phase NA Completed

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡